Governments and traders spent Monday assessing the energy fallout from the expanding war involving Iran, as disruption around the Strait of Hormuz renewed fears over one of the world’s most important oil corridors. Since the conflict began on Feb. 28, tanker traffic through the strait has largely stalled, raising concern that a prolonged interruption could restrict supply well beyond the…
Preliminary testing by California health authorities detected bacteria capable of producing botulism toxin in ByHeart Whole Nutrition Infant Formula, triggering a voluntary recall of two product lots. The affected codes are 206VABP/251261P2 and 206VABP/251131P2, each labeled “Use by 01 Dec 2026.” The U.S. Food and Drug Administration (FDA) has advised parents and caregivers to stop using cans from these lots,…
Honda Motor Co. reported a steep deterioration in earnings for the first fiscal half through September 2025, underscoring how trade frictions and currency swings have cut into margins despite resilient demand in parts of the business. Net profit fell 37% to ¥311.8 billion (about US$2.0 billion) from ¥494.6 billion a year earlier, while revenue slipped 1.5% to ¥10.6 trillion from…
Denny’s Corporation announced it will be acquired by a consortium of investors and taken private in a transaction valued at about $620 million, including debt. The deal, unanimously approved by the board, provides $6.25 in cash per share, totaling roughly $322 million in equity value. The buyer group includes TriArtisan Capital Advisors, Treville Capital Group, and Yadav Enterprises, one of…
Epic Games and Google said they reached a “comprehensive settlement” to end a five-year legal battle over the Google Play app marketplace on Android, according to a joint filing in federal court in San Francisco. The agreement, which still requires approval from the U.S. District Judge James Donato, aims to “put their disputes aside” while making Android a more competitive…
Novo Nordisk has raised its offer for Metsera to as much as $10 billion, intensifying a takeover fight with Pfizer for the clinical-stage obesity-drug developer. Metsera said the revised proposal includes $62.20 in cash per share plus a $24 contingent value right (CVR) tied to development and regulatory milestones, up from Novo’s prior bid that peaked at $9 billion. In…
Kimberly-Clark will acquire Kenvue, the maker of Tylenol, in a cash-and-stock transaction valued at about $48.7 billion, bringing a wide portfolio of everyday brands under one roof. The combined company will house marquee names including Kleenex, Huggies, Cottonelle, Band-Aid, Listerine, and Neutrogena, creating one of the sector’s largest consumer-health and personal-care players. Post-merger, Kimberly-Clark shareholders are expected to own about…
